메뉴 건너뛰기




Volumn 84, Issue 3, 2014, Pages 271-274

Vinorelbine and gemcitabine as second- or third-line therapy for malignant pleural mesothelioma

Author keywords

Chemotherapy; Gemcitabine; Mesothelioma; Vinorelbine

Indexed keywords

CISPLATIN; GEMCITABINE; NAVELBINE; PEMETREXED; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; VINBLASTINE;

EID: 84901916245     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2014.03.006     Document Type: Article
Times cited : (94)

References (14)
  • 1
    • 0041629528 scopus 로고    scopus 로고
    • Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
    • Vogelzang N.J., Rusthoven J.J., Symanowski J., Denham C., Kaukel E., Ruffie P., et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003, 21(14):2636-2644.
    • (2003) J Clin Oncol , vol.21 , Issue.14 , pp. 2636-2644
    • Vogelzang, N.J.1    Rusthoven, J.J.2    Symanowski, J.3    Denham, C.4    Kaukel, E.5    Ruffie, P.6
  • 2
    • 57649088756 scopus 로고    scopus 로고
    • The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma
    • Stebbing J., Powles T., McPherson K., Shamash J., Wells P., Sheaff M.T., et al. The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma. Lung Cancer 2009, 63(1):94-97.
    • (2009) Lung Cancer , vol.63 , Issue.1 , pp. 94-97
    • Stebbing, J.1    Powles, T.2    McPherson, K.3    Shamash, J.4    Wells, P.5    Sheaff, M.T.6
  • 3
    • 43449092540 scopus 로고    scopus 로고
    • Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial
    • Muers M.F., Stephens R.J., Fisher P., Darlison L., Higgs C.M., Lowry E., et al. Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial. Lancet 2008, 371(9625):1685-1694.
    • (2008) Lancet , vol.371 , Issue.9625 , pp. 1685-1694
    • Muers, M.F.1    Stephens, R.J.2    Fisher, P.3    Darlison, L.4    Higgs, C.M.5    Lowry, E.6
  • 4
    • 84901932964 scopus 로고    scopus 로고
    • Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma
    • [Epub ahead of print]
    • Zucali P.A., Perrino M., Lorenzi E., Ceresoli G.L., De Vincenzo F., Simonelli M., et al. Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma. Lung Cancer 2013, [Epub ahead of print]. 10.1016/j.lungcan.2013.11.011.
    • (2013) Lung Cancer
    • Zucali, P.A.1    Perrino, M.2    Lorenzi, E.3    Ceresoli, G.L.4    De Vincenzo, F.5    Simonelli, M.6
  • 5
    • 0033564135 scopus 로고    scopus 로고
    • A phase II study of gemcitabine in patients with malignant pleural mesothelioma. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group
    • van Meerbeeck J.P., Baas P., Debruyne C., Groen H.J., Manegold C., Ardizzoni A., et al. A phase II study of gemcitabine in patients with malignant pleural mesothelioma. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. Cancer 1999, 85(12):2577-2582.
    • (1999) Cancer , vol.85 , Issue.12 , pp. 2577-2582
    • van Meerbeeck, J.P.1    Baas, P.2    Debruyne, C.3    Groen, H.J.4    Manegold, C.5    Ardizzoni, A.6
  • 6
    • 21344471421 scopus 로고    scopus 로고
    • Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma
    • Manegold C., Symanowski J., Gatzemeier U., Reck M., von Pawel J., Kortsik C., et al. Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma. Ann Oncol 2005, 16(6):923-927.
    • (2005) Ann Oncol , vol.16 , Issue.6 , pp. 923-927
    • Manegold, C.1    Symanowski, J.2    Gatzemeier, U.3    Reck, M.4    von Pawel, J.5    Kortsik, C.6
  • 7
    • 0035141576 scopus 로고    scopus 로고
    • Gemcitabine for malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B
    • Kindler H.L., Millard F., Herndon J.E., Vogelzang N.J., Suzuki Y., Green M.R. Gemcitabine for malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B. Lung Cancer 2001, 31(2-3):311-317.
    • (2001) Lung Cancer , vol.31 , Issue.2-3 , pp. 311-317
    • Kindler, H.L.1    Millard, F.2    Herndon, J.E.3    Vogelzang, N.J.4    Suzuki, Y.5    Green, M.R.6
  • 8
    • 0037183683 scopus 로고    scopus 로고
    • A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma
    • Nowak A.K., Byrne M.J., Williamson R., Ryan G., Segal A., Fielding D., et al. A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma. Br J Cancer 2002, 87(5):491-496.
    • (2002) Br J Cancer , vol.87 , Issue.5 , pp. 491-496
    • Nowak, A.K.1    Byrne, M.J.2    Williamson, R.3    Ryan, G.4    Segal, A.5    Fielding, D.6
  • 9
    • 18244404869 scopus 로고    scopus 로고
    • Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma
    • van Haarst J.M., Baas P., Manegold C., Schouwink J.H., Burgers J.A., de Bruin H.G., et al. Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma. Br J Cancer 2002, 86(3):342-345.
    • (2002) Br J Cancer , vol.86 , Issue.3 , pp. 342-345
    • van Haarst, J.M.1    Baas, P.2    Manegold, C.3    Schouwink, J.H.4    Burgers, J.A.5    de Bruin, H.G.6
  • 10
    • 0032895398 scopus 로고    scopus 로고
    • Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study
    • Byrne M.J., Davidson J.A., Musk A.W., Dewar J., van Hazel G., Buck M., et al. Cisplatin and gemcitabine treatment for malignant mesothelioma: a phase II study. J Clin Oncol 1999, 17(1):25-30.
    • (1999) J Clin Oncol , vol.17 , Issue.1 , pp. 25-30
    • Byrne, M.J.1    Davidson, J.A.2    Musk, A.W.3    Dewar, J.4    van Hazel, G.5    Buck, M.6
  • 11
    • 41149175598 scopus 로고    scopus 로고
    • Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma
    • Zucali P.A., Ceresoli G.L., Garassino I., De Vincenzo F., Cavina R., Campagnoli E., et al. Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma. Cancer 2008, 112(7):1555-1561.
    • (2008) Cancer , vol.112 , Issue.7 , pp. 1555-1561
    • Zucali, P.A.1    Ceresoli, G.L.2    Garassino, I.3    De Vincenzo, F.4    Cavina, R.5    Campagnoli, E.6
  • 12
    • 1342267614 scopus 로고    scopus 로고
    • Modified RECIST criteria for assessment of response in malignant pleural mesothelioma
    • Byrne M.J., Nowak A.K. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 2004, 15(2):257-260.
    • (2004) Ann Oncol , vol.15 , Issue.2 , pp. 257-260
    • Byrne, M.J.1    Nowak, A.K.2
  • 13
    • 84858403099 scopus 로고    scopus 로고
    • VANTAGE 014: vorinostat (V) in patients with advanced malignant pleural mesothelioma (MPM) who have failed prior pemetrexed and either cisplatin or carboplatin therapy: a phase III, randomized, double-blind, placebo-controlled trial
    • Krug L.M., Kindler H., Calvert C., Manegold C., Tsao A.S., Fennell D., et al. VANTAGE 014: vorinostat (V) in patients with advanced malignant pleural mesothelioma (MPM) who have failed prior pemetrexed and either cisplatin or carboplatin therapy: a phase III, randomized, double-blind, placebo-controlled trial. Eur J Cancer 2011, 47(2):2-3.
    • (2011) Eur J Cancer , vol.47 , Issue.2 , pp. 2-3
    • Krug, L.M.1    Kindler, H.2    Calvert, C.3    Manegold, C.4    Tsao, A.S.5    Fennell, D.6
  • 14
    • 84860674283 scopus 로고    scopus 로고
    • BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesothelioma
    • Busacca S., Sheaff M., Arthur K., Gray S.G., O'Byrne K.J., Richard D.J., et al. BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesothelioma. J Pathol 2012, 227(2):200-208.
    • (2012) J Pathol , vol.227 , Issue.2 , pp. 200-208
    • Busacca, S.1    Sheaff, M.2    Arthur, K.3    Gray, S.G.4    O'Byrne, K.J.5    Richard, D.J.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.